Last updated: 2026-09-11 07:48:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Freenome, Inc. (FRNM) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $14.80, with a market capitalization of $1.69B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.97 to $17.18. This page covers its latest market performance, valuation, price trends and company information.
$1.69B | |
$15.64 | |
$17.18 | |
$9.97 | |
$15.75 | |
704.16K | |
861.82K | |
-- | |
$17.18 | |
$9.97 | |
-- | |
-- |
Freenome, Inc. (FRNM) last closed at $15.75 as of 2026-09-10 23:31:00, unchanged from the previous close of $15.75.
During the latest regular trading session, FRNM traded between $9.97 and $17.18, with a volume of 704.16K shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Freenome, Inc. (FRNM) moved from $15.25 to $14.80, representing a decline of 2.96% ($0.45).
The stock traded between $14.67 and $17.18 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 886.74 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 67.0%
FRNM is currently trading at $14.80, placing it 67.0% of the way from its 52-week low of $9.97 to its 52-week high of $17.18. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Freenome, Inc. (FRNM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.